1. Home
  2. PROF vs GALT Comparison

PROF vs GALT Comparison

Compare PROF & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$7.88

Market Cap

230.4M

Sector

Health Care

ML Signal

HOLD

Logo Galectin Therapeutics Inc.

GALT

Galectin Therapeutics Inc.

HOLD

Current Price

$3.03

Market Cap

203.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
GALT
Founded
N/A
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.4M
203.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PROF
GALT
Price
$7.88
$3.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$12.00
$8.50
AVG Volume (30 Days)
231.5K
415.7K
Earning Date
03-05-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,297,000.00
N/A
Revenue This Year
$64.23
N/A
Revenue Next Year
$113.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
67.94
N/A
52 Week Low
$3.76
$1.12
52 Week High
$8.95
$7.13

Technical Indicators

Market Signals
Indicator
PROF
GALT
Relative Strength Index (RSI) 52.80 37.73
Support Level $7.22 $2.76
Resistance Level $8.15 $3.56
Average True Range (ATR) 0.56 0.22
MACD -0.09 0.05
Stochastic Oscillator 37.86 31.25

Price Performance

Historical Comparison
PROF
GALT

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About GALT Galectin Therapeutics Inc.

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Share on Social Networks: